Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
State University of New York - Upstate Medical University |
---|---|
Information provided by: | State University of New York - Upstate Medical University |
ClinicalTrials.gov Identifier: | NCT00643175 |
Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studies have shown that prior fracture increases the risk for further fracture. In 2004 the Surgeon General released a report on osteoporosis, the details of which include multi-disciplinary treatment of osteoporotic fractures. Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Possible planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.
Condition | Intervention |
---|---|
Osteoporosis |
Behavioral: Automated follow up |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Estimated Enrollment: | 20 |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Osteoporosis in patients with fragility hip fractures.
|
Behavioral: Automated follow up
Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.
|
Ages Eligible for Study: | 55 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Using the existing WebCAIS order system, an automated endocrinology consult and appropriate laboratory studies will be drawn on all non-traumatic hip fractures. Data from these patients will be collected in a prospective study, and the patients will be followed up over time to check adherence to osteoporotic medical therapy and future incidence of re-fracture.
Inclusion:
Exclusion criteria:
Responsible Party: | SUNY Upstate Medical University ( Andrew Grose, MD ) |
Study ID Numbers: | osteoporotic hip fracture |
Study First Received: | March 24, 2008 |
Last Updated: | March 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00643175 History of Changes |
Health Authority: | United States: Institutional Review Board |
The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures. |
Hip Fractures Musculoskeletal Diseases Fractures, Bone |
Osteoporosis Bone Diseases, Metabolic Bone Diseases |
Musculoskeletal Diseases Osteoporosis Bone Diseases, Metabolic Bone Diseases |